Octenidine/prednicarbate

Drug Profile

Octenidine/prednicarbate

Alternative Names: LAS 189961/LAS 189962; LAS 189962/LAS 189961; LAS-41003; Prednicarbate/octenidine

Latest Information Update: 12 Nov 2016

Price : $50

At a glance

  • Originator Laboratorios Almirall
  • Developer Almirall S.A.
  • Class Anti-inflammatories; Antifungals; Antiseptics; Glucocorticoids; Skin disorder therapies
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Candidiasis; Eczema; Tinea pedis

Most Recent Events

No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top